Mahesh Karande
2021
In 2021, Mahesh Karande earned a total compensation of $4.7M as President and Chief Executive Officer at Omega Therapeutics, a 400% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $267,500 |
|---|---|
| Option Awards | $3,656,593 |
| Salary | $512,427 |
| Other | $259,778 |
| Total | $4,696,298 |
Karande received $3.7M in option awards, accounting for 78% of the total pay in 2021.
Karande also received $267.5K in non-equity incentive plan, $512.4K in salary and $259.8K in other compensation.
Rankings
In 2021, Mahesh Karande's compensation ranked 2,810th out of 12,406 executives tracked by ExecPay. In other words, Karande earned more than 77.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,810 out of 12,406 | 77th |
Division Manufacturing | 1,112 out of 5,492 | 80th |
Major group Chemicals And Allied Products | 439 out of 2,368 | 82nd |
Industry group Drugs | 383 out of 2,089 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 111 out of 452 | 75th |
Source: SEC filing on April 29, 2022.
Karande's colleagues
We found two more compensation records of executives who worked with Mahesh Karande at Omega Therapeutics in 2021.